Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
iRadimed Corporation logo

iRadimed Corporation

Sector: Healthcare   

Industry: Medical Devices

42.20
 
USD
  
0.23
  
(0.55%)
Optionable: No  Market Cap: 537 M  90-day average vol: 51,491

Previous close: 41.97  Open: 42.04  Bid: 16.78  Ask: 59.0
52 week range    
36.12   
   51.04
Peers   
MLSS / 
NUVA / 
COO / 
Last updated: Monday 4th March 2024
45
MarketXLS Rank
40
Value
30
Technical
65
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

IRMD Cash Flow

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in inventories-847576.0-308409.0-1 M-334113.0-121591.0123680.0-282904.0-393316.0-1 M
(Increase) Decrease in other current assets-182738.0-130075.0-688145.0-164517.0-79295.0-596755.0389932.0523607.0-341127.0
(Increase) Decrease in other current liabilities186172.0501463.02 M932569.0-6035.0700348.025812.048062.0384141.0
(Increase) Decrease in other working capital-1388.0-170143.0-61139.026557.0
(Increase) Decrease in payables201693.02 M1 M-688351.0-1 M609840.0-2 M-762479.04 M
(Increase) Decrease in receivables130721.0-2 M75297.0-201591.0-446896.0-3 M3 M-575543.0-8 M
AssetImpairmentCharge62069.0106522.094186.069199.0111790.079452.0-59294.0132093.055737.0
CapitalExpenditureReported606288.0314839.02 M824763.0264665.0485812.0636746.0741759.02 M
Cash at beginning of period2 M9 M19 M18 M18 M28 M43 M50 M62 M
Cash at end of period9 M19 M18 M18 M28 M43 M50 M62 M58 M
Cash flow3 M8 M9 M3 M7 M10 M6 M11 M10 M
CashFlowFromContinuingInvestingActivities-8 M-61469.0-2 M-1 M2 M3 M246969.0648241.0-1 M
ChangeInAccountPayable201693.0376293.01113.0-523449.034161.0149319.0-403567.030414.01 M
ChangeInAccruedExpense-14997.0-35103.0
ChangeInIncomeTaxPayable-213416.02 M917707.0-155310.0-1 M-3055.0-1 M-829227.03 M
ChangeInPayablesAndAccruedExpense186696.02 M1 M-688351.0-1 M609840.0-2 M-762479.04 M
ChangeInPrepaidAssets-203100.0-31977.0-702573.0-1 M-407461.0-487650.0-1 M-1 M305936.0
ChangeInTaxPayable-228413.02 M1 M-164902.0-1 M460521.0-2 M-792893.03 M
ChangeInWorkingCapital-731213.0240789.052997.0-2 M-2 M-3 M-339146.0-2 M-5 M
ChangesInAccountReceivables130721.0-2 M75297.0-201591.0-446896.0-3 M3 M-575543.0-8 M
CommonStockDividendPaid-13 M
CommonStockPayments-10 M-2 M
Current deferred income taxes-165228.0-2 M-603553.0
Deferred income taxes-165228.0-2 M-603553.0
Depreciation149056.0223942.0955809.01 M1 M1 M1 M1 M670673.0
Depreciation unreconciled149056.0223942.0955809.01 M1 M1 M1 M1 M670673.0
DepreciationAndAmortization149056.0223942.0955809.01 M1 M1 M1 M1 M670673.0
FinancingCashFlow13 M2 M-9 M-2 M929874.02 M522482.024425.0-13 M
Free cash flow2 M7 M8 M3 M7 M10 M5 M11 M8 M
GainLossOnInvestmentSecurities3575.083957.06757.028036.0-10764.0-17272.0-18593.0-8025.0
GainLossOnSaleOfPPE6496.05544.0-1741.0
IncomeTaxPaidSupplementalData1 M3 M3 M1 M1 M12000.0970000.02 M
InterestPaidSupplementalData1 M
Issuance of capital stock14 M
Issuance of debt-6333.0
IssuanceOfCapitalStock14 M
IssuanceOfDebt-6333.0
Net cash from financing activities13 M2 M-9 M-2 M929874.02 M522482.024425.0-13 M
Net cash from investing activities-8 M-61469.0-2 M-1 M2 M3 M246969.0648241.0-1 M
Net cash from operating activities3 M8 M9 M3 M7 M10 M6 M11 M10 M
Net change in cash & cash equivalents7 M10 M-2 M492105.010 M15 M7 M12 M-4 M
Net income from continuing operations2 M8 M7 M499764.06 M10 M1 M9 M13 M
NetCommonStockIssuance14 M-10 M-2 M
NetInvestmentPropertiesPurchaseAndSale-8 M253370.0-417486.0-198735.02 M4 M883715.01 M500000.0
NetInvestmentPurchaseAndSale-8 M253370.0-417486.0-198735.02 M4 M883715.01 M500000.0
NetIssuancePaymentsOfDebt-6333.0
NetPPEPurchaseAndSale-606288.0-314839.0-2 M-824763.0-264665.0-485812.0-636746.0-741759.0-2 M
Operating (gains) losses589536.046925.0-169025.0483827.0318021.0353124.0-462203.01 M47564.0
Other financing charges net-2 M2 M603553.0-158140.0-309561.0-473143.0-1 M-598817.0-293981.0
Other non-cash items693203.01 M2 M3 M2 M2 M4 M2 M2 M
Payment of cash dividends13 M
PensionAndEmployeeBenefitExpense589536.043350.0-252982.0477070.0289985.0363888.0-451427.01 M57330.0
ProceedsFromIssuanceOfWarrants105000.0597508.0247133.076366.01 M2 M2 M623242.0
ProceedsFromStockOptionExercised105000.0623242.0146708.0
Purchase of Float term investments-8 M253370.0-417486.0-198735.0-1 M
Purchase of property plant & equipment-606288.0-314839.0-2 M-824763.0-264665.0-485812.0-636746.0-741759.0-2 M
PurchaseOfInvestment-8 M253370.0-417486.0-198735.0-1 M
PurchaseOfPPE-606288.0-314839.0-2 M-824763.0-264665.0-485812.0-636746.0-741759.0-2 M
RepaymentOfDebt-6333.0
Repurchase of capital stock-10 M-2 M
Sale of short term investments3 M4 M883715.01 M500000.0
SaleOfInvestment3 M4 M883715.01 M500000.0
ShortTermDebtPayments-6333.0
StockBasedCompensation724063.01 M2 M2 M2 M2 M4 M1 M1 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University